The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial (Q33526184)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

0 references

0 references

chronic heart failure

1 reference

based on heuristic

inferred from title

Valentina Milani

object named as

Valentina Milani

7

0 references

Aldo P. Maggioni

object named as

Aldo P Maggioni

11

0 references

13

object named as

Luigi Tavazzi

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

Serge Masson

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Roberto Latini

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Emanuele Carbonieri

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Luciano Moretti

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Maria Grazia Rossi

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Santo Ciricugno

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Roberto Marchioli

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Joachim Struck

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Andreas Bergmann

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Gianni Tognoni

12

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

GISSI-HF Investigators

14

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

22 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

338-347

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

The Seattle Heart Failure Model: prediction of survival in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Biomarkers in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Atrial natriuretic peptide concentrations in blood from right atrium in patient with severe right heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Development and Clinical Application of a New Method for the Radioimmunoassay of Arginine Vasopressin in Human Plasma

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Measurement of endothelin: clinical and research use.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

State of the art: using natriuretic peptide levels in clinical practice

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Incremental prognostic value of changes in B-type natriuretic peptide in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP206

21 January 2018

Identifiers

10.1093/EURJHF/HFP206

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33526184&oldid=1541562603"